Tesla
TSLA
Apple
AAPL
Meta Platforms
META
4
Microsoft
MSFT
5
Petroleo Brasileiro SA Petrobras
PBR
US Stock MarketDetailed Quotes
SGMT Sagimet Biosciences
- 3.990
- -0.060-1.48%
Close Mar 21 16:00 ET
- 3.990
- 0.0000.00%
Post 20:01 ET
128.46MMarket Cap-2.75P/E (TTM)
4.014High3.890Low227.64KVolume3.980Open4.050Pre Close898.20KTurnover1.17%Turnover RatioLossP/E (Static)32.20MShares7.38052wk High0.82P/B77.52MFloat Cap2.39052wk Low--Dividend TTM19.43MShs Float20.710Historical High--Div YieldTTM3.06%Amplitude2.130Historical Low3.945Avg Price1Lot Size
Sagimet Biosciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -78.55%-42.44M | -55.64%-11.02M | -404.49%-19.57M | 1.50%-5.63M | 12.37%-6.21M | 2.96%-23.77M | 4.96%-7.08M | 37.78%-3.88M | 6.81%-5.72M | -51.85%-7.08M |
| Net income from continuing operations | -63.46%-45.57M | -98.76%-16.2M | -130.11%-14.62M | -19.65%-8.12M | -0.64%-6.63M | 8.60%-27.88M | -13.29%-8.15M | 14.92%-6.35M | 4.46%-6.79M | 24.59%-6.59M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | -33.33%-4K | ---- | ---- | ---- | 200.00%2K |
| Other non cash items | 4.32%145K | 2.78%37K | 5.71%37K | 2.94%35K | 5.88%36K | 6.92%139K | 9.09%36K | 6.06%35K | 6.25%34K | 6.25%34K |
| Change In working capital | -7.16%-1.05M | 1,407.86%3.66M | -1,123.17%-6.01M | 7,485.00%1.48M | 85.69%-181K | -123.21%-978K | 69.86%-280K | -34.78%587K | -103.39%-20K | -134.63%-1.27M |
| -Change in prepaid assets | 99.47%-5K | 679.36%3.26M | -463.27%-4.31M | -0.97%408K | 1,829.73%640K | -166.30%-952K | -610.91%-562K | -532.23%-765K | 520.41%412K | -102.39%-37K |
| -Change in payables and accrued expense | -855.83%-907K | 38.75%444K | -219.51%-1.66M | 375.51%1.09M | 34.45%-782K | -95.88%120K | 131.84%320K | 31.66%1.39M | -155.85%-396K | -155.33%-1.19M |
| -Change in other current liabilities | 6.85%-136K | 0.00%-38K | 0.00%-37K | 38.89%-22K | -11.43%-39K | -6.57%-146K | -11.76%-38K | -8.82%-37K | -71.43%-36K | 27.08%-35K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -78.55%-42.44M | -55.64%-11.02M | -404.49%-19.57M | 1.50%-5.63M | 12.37%-6.21M | 2.96%-23.77M | 4.96%-7.08M | 37.78%-3.88M | 6.81%-5.72M | -51.85%-7.08M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -590.33%-61.68M | 150.20%9.85M | 624K | -687.16%-75.16M | -84.54%3M | 139.30%12.58M | -460.93%-19.62M | 0 | 130.88%12.8M | 19.4M |
| Net investment purchase and sale | -590.33%-61.68M | 150.20%9.85M | --624K | -687.16%-75.16M | -84.54%3M | 139.30%12.58M | -460.93%-19.62M | --0 | 130.88%12.8M | --19.4M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -590.33%-61.68M | 150.20%9.85M | --624K | -687.16%-75.16M | -84.54%3M | 139.30%12.58M | -460.93%-19.62M | --0 | 130.88%12.8M | --19.4M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 21.65%104.82M | 0 | 0 | 97.03%-27K | 77,192.65%104.85M | 118,136.99%86.17M | 0 | 87.21M | -2,933.33%-910K | -1,233.33%-136K |
| Net common stock issuance | 17.92%105.75M | --0 | --0 | --0 | --105.75M | --89.68M | --3.52M | --86.16M | --0 | --0 |
| Proceeds from stock option exercised by employees | 1,800.00%114K | --0 | --0 | --0 | --114K | -50.00%6K | --0 | --6K | --0 | --0 |
| Net other financing activities | 70.30%-1.05M | --0 | --0 | 97.03%-27K | -648.53%-1.02M | -4,038.82%-3.52M | ---- | ---- | ---910K | ---136K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 21.65%104.82M | --0 | --0 | 97.03%-27K | 77,192.65%104.85M | 118,136.99%86.17M | --0 | --87.21M | -2,933.33%-910K | -1,233.33%-136K |
| Net cash flow | ||||||||||
| Beginning cash position | 47,456.33%75.14M | -24.38%77.01M | 418.47%95.96M | 1,332.78%176.78M | 47,456.33%75.14M | -99.72%158K | 4,466.91%101.84M | 314.61%18.51M | -76.31%12.34M | -99.72%158K |
| Current changes in cash | -99.07%701K | 95.60%-1.17M | -122.73%-18.95M | -1,409.85%-80.82M | 734.47%101.64M | 232.54%74.98M | -1,188.75%-26.7M | 3,830.26%83.33M | 112.96%6.17M | 361.77%12.18M |
| End cash Position | 0.93%75.84M | 0.93%75.84M | -24.38%77.01M | 418.47%95.96M | 1,332.78%176.78M | 47,456.33%75.14M | 47,456.33%75.14M | 4,466.91%101.84M | 314.61%18.51M | -76.31%12.34M |
| Free cash flow | -78.55%-42.44M | -55.64%-11.02M | -404.49%-19.57M | 1.50%-5.63M | 12.37%-6.21M | 2.96%-23.77M | 4.96%-7.08M | 37.78%-3.88M | 6.81%-5.72M | -51.85%-7.08M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call